NEDD4 has been reported as both tumour suppressor and oncogene (Kim et al, 2008; March et al, 2011; Eide et al, 2013; Zeng et al, 2014; Lu et al, 2016), while the role of NEDD4L in cancer is largely unknown. Here, NEDD4L is linked to neoplasm.